Truqap (capivasertib)

$9,501.30

AKT inhibitor for breast cancer

SKU: truqap-capivasertib Category: Tags: , ,

Description

Truqap (capivasertib) is an AKT inhibitor used with fulvestrant for HR+/HER2- advanced breast cancer with specific alterations.

Reviews

There are no reviews yet.

Be the first to review “Truqap (capivasertib)”

Your email address will not be published. Required fields are marked *